Operation Trialblazer is a department-wide HHS effort, launched June 22, 2026 with FDA, NIH, ARPA-H and OIG, aimed at cutting US clinical trial timelines roughly in half. It bundles a rolling IND submission pilot, a push to simplify IND requirements, and revised FDA thinking on how much confirmatory evidence a pivotal trial needs.
Free sandbox · No credit card · 21 CFR Part 11 aligned
protocol_v3.pdf
Draft study
Jun 22, 2026
HHS launch date for Operation Trialblazer
~50%
HHS's stated goal for cutting US trial timelines
6-12 mo
FDA estimate of time saved by speeding up Phase 1 alone
5
agencies involved: HHS, FDA, NIH, ARPA-H, OIG
The initiative
Operation Trialblazer is not one single new rule. It is an umbrella HHS initiative that bundles several separate efforts: the Expedited IND Pilot Program's rolling review of IND components, a broader push to cut down what an IND submission itself has to contain, and revised FDA thinking, published as a June 2026 draft, on when one strong pivotal trial can support approval instead of the traditional two.
Blank eCRF · no subject data
Visit by form matrix
| Form | SCR | D1 | W2 | W4 | W8 | EOS |
|---|---|---|---|---|---|---|
| Demographics | X | |||||
| Vital signs | X | X | X | X | X | X |
| Laboratory | X | X | X | |||
| ECG | X | X |
3. Was the ECG performed?
☐ Yes☐ No
If No, complete question 4.
What this means for a sponsor
FDA estimates targeting Phase 1 alone could shave 6-12 months off a program's overall timeline; this applies to selected pilot pairs first.
HHS's proposal is directional and case-by-case; it does not remove the need for a well-designed, well-run pivotal trial.
Faster review does not mean a lower evidence bar; audit trails, edit checks and a clean casebook still matter exactly as much.
Confirm the current status of any specific initiative under Operation Trialblazer directly with FDA before relying on it for a filing decision.
The part that does not change
Whatever the review timeline looks like, the confirmatory trial behind it still needs to hold up. Capture's edit checks raise an auto-query the moment a value breaks a rule, and the field-level audit trail keeps the original value, the change, and the reason, permanently.
Edit checks / auto-queries
2Type
Range High
Operator
Greater than
Value
180
Priority: High
Type
Range Low
Operator
Less than
Value
80
Priority: Normal
Query raised automatically
Value 192 violates limit (180). Please verify.
Before you switch
Free sandbox with every feature, no credit card, so you can test before committing.
Field-level audit trail and OTP-verified e-signatures regardless of which FDA review track your study is on.
AI drafts the visit schedule and forms from your protocol; you review before anything is saved.
Bring an existing protocol or CRF set across; the AI reads PDF, DOCX and DOC files.
Email support, typically under 24 hours, plus documentation on Enterprise.
Free sandbox with every feature. No credit card, no sales call.
A department-wide HHS initiative, launched June 22, 2026 with FDA, NIH, ARPA-H and OIG, aimed at cutting US clinical trial timelines roughly in half, bundling a rolling IND pilot, simplified IND requirements, and revised confirmatory-evidence guidance.
The pilot is one specific program under the broader Operation Trialblazer initiative; it covers the rolling IND component review piece specifically.
HHS has proposed that direction in appropriate cases, in a June 2026 draft. It is not a blanket rule change. Confirm the current guidance status directly with FDA before relying on it for a filing.
No. This page explains the publicly announced initiative; Capture is not affiliated with it.
No. The same audit trail, edit checks and e-signature controls matter regardless of how quickly FDA reviews the submission.
FDA.gov and HHS.gov publish the official Operation Trialblazer materials and program pages; check those directly for the current status.
Yes. The free sandbox includes every feature with sample data, no credit card required.
Keep exploring
FDA Expedited IND Pilot Program guide
The rolling-review pilot bundled under this initiative.
Bayesian clinical trial design guide
Another 2026 FDA methodology change worth planning around.
ICH E6(R3) guide
The GCP guidance running alongside this initiative.
Audit trail software
The record that still needs to hold up under any review track.
Query management software
How auto-queries keep the data behind a filing clean.
Free sandbox with every feature. No credit card, no sales call.